A New Canadian Plant-Based COVID-19 Vaccine Is Looking For 30,000 People For Testing

You can apply to participate in the clinical trial.
A New Canadian Plant-Based COVID-19 Vaccine Is Looking For 30,000 People For Testing

On Tuesday, March 16, Quebec-based Medicago announced that they will be moving into Phase 3 of clinical testing of their plant-based COVID-19 vaccine candidate. 

Medicago's COVID-19 vaccine candidate is "plant-derived," and, as it moves to late-stage clinical testing, 30,000 people will be able to volunteer for the trials. 

Editor's Choice: Here Are All The Essential Workers Who Can Get Vaccines First In Ontario

"The trial will take place in 10 countries pending regulatory approvals, starting with Canada and the United States," said a press release

They'll be testing a range of "males and females from ethnically and racially diverse populations." 

You must be over the age of 18 to apply and must not have received a COVID-19 vaccine or diagnosis. 

Health Canada has a robust website with all the latest information on the vaccines and can answer any questions you may have. Click here for more information.

More from Narcity

Comments 💬

Our comment section is a place to promote self-expression, freedom of speech and positivity. We encourage discussion and debate, but our pages must remain a safe space where everyone feels comfortable and the environment is respectful.

In order to make this possible, we monitor comments to keep spam, hate speech, violence, and vulgarity off our pages. Comments are moderated according to our Community Guidelines.

Please note that Narcity Media does not endorse the opinions expressed in the comment section of an article. Narcity Media has the right to remove comments, ban or suspend any user without notice, or close a story’s comment section at any time.

First and last names will appear with each comment and the use of pseudonyms is prohibited. By commenting, you acknowledge that Narcity Media has the right to use & distribute your content across our properties.